ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate - ספריי - fluticasone furoate 27.5 mcg/dose - fluticasone furoate - fluticasone - avamys (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 500 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma. symptomatic treatment of chronic obstructive pulmonary disease.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 250 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma. symptomatic treatment of chronic obstructive pulmonary disease.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 50 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף לשאיפה - fluticasone propionate 250 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma. symptomatic treatment of chronic obstructive pulmonary disease.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף לשאיפה - fluticasone propionate 125 mcg/dose - fluticasone - fluticasone - prophylactic management of all grades of asthma.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 g / 100 g - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hayfever, and perennial rhinitis. perenial rhinitis in children of the age of 4 years.